ARCHIVES

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Huntsman Cancer Institute Joins NCCN: Howard cancer Center To Honor Mandela

November 7, 1997

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

Number of Cancer Deaths Rise Slightly Due To Population Growth And Aging.

February 22, 2008

FCRF Recompetition Intriguing, Involved Various Possibility

May 9, 1986

Alcohol Consumption Does Not Impact Survival of Breast Cancer

April 26, 2013

Nutrition Research Priority Areas Outlined By NCI

December 6, 1974